Compare Sony Group Corp (SONY) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sony Group Corp vs Twist Bioscience Corp — how do they compare? Sony Group Corp trades at $21.11 (market cap $125.96B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Sony Group Corp is far larger — about 23.1× Twist Bioscience Corp's market cap, and Sony Group Corp pays a 0.75% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| SONY | TWST | |
|---|---|---|
Market Cap | $125.96B | $5.45B |
Sector | Technology | Health |
52-Week High | $30.26 | $102.88 |
52-Week Low | $19.32 | $24.16 |
Enterprise Value | $122.45B | $5.37B |
Dividend Yield | 0.75% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sony Group Corp
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
